|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Friday, June 16
by
All About MS
on Fri 16 Jun 2006 07:13 AM CST
HealthTalk Inc., a pioneer in patient education delivering live and web-based programs on the latest treatments and research news, is hosting a live webcast for Multiple Sclerosis patients, their families, and caregivers. Experts will be discussing the recall and the re-approval of the drug Tysabri as well as its benefits, safety, and risk management. Consumers can more »
by
All About MS
on Fri 16 Jun 2006 02:00 AM CST
Betaferon(R) (interferon beta-1b) has been granted marketing authorization by the European Commission for an extension of its indication to include the treatment of patients with a first clinical event suggestive of multiple sclerosis (MS) in all 25 European member states, as well as Iceland and Norway. With this approval, Betaferon becomes more »
|
||